Scientists say a new drug can prevent heart attacks and strokes by cutting bad cholesterol levels. A trial of 27-thousand patients already taking statins, found those who took evolocumab saw their bad cholesterol fall by around 60 per cent on average. The study found that for every 74 people who took the drug for two years one heart attack or stroke was prevented.
Staples Says Mental Health Comes First As Rosslare Chair
Gorey Pupil Honoured with National Farm Safety Ambassador Award
Kilmore Quay RNLI Crew Rush to Aid Yacht Taking on Water During Blessing of the Boats
Two Women Arrested After €900 Drug Seizure in Kilmore Garda Operation